Stockreport

Omeros Corporation Streamlines Path to Biologics License Application for OMS721 in HSCT-TMA Following Meeting with FDA

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF Patient Data from Existing Single-Arm Study Will Form the Basis for BLA; No Historical Control Required SEATTLE--(BUSINESS WIRE)-- Omeros Corp [Read more]